Menu Close

Latest News

Latest news and updates

NIHR funds community COVID-19 antiviral trial

Date: 22 November 2021

The National Institute for Health Research (NIHR) has awarded funding to the University of Oxford – working with several UK universities – to carry out a first-of-its-kind clinical trial, testing novel antiviral COVID-19 treatments for use early on in the illness, by people in the community with COVID-19 who are at higher risk of complications.

The Platform Adaptive trial of NOvel antiviRals for eArly treatMent of COVID-19 In the Community (PANORAMIC) is a national priority trial, and as soon as it is set up for delivery – will be open to eligible participants from across the UK.

PANORAMIC has been designed as a ‘platform clinical trial’, meaning it can rapidly evaluate several antiviral treatments over time that could help people at high risk of COVID-19 recover sooner, prevent the need for hospital admission and so ease the burden on the NHS.

Further details about the trial will follow soon. Read more.

Click to go back to News Listing

Latest News
News

Latest News

Click for the latest news and updates from the R&D Community.
Virtual Courses
Learning & Development

Virtual Courses

Virtual classroom courses covering R&D topics
RDF21 News
News

RDF21 News

Find out all the latest information about our Annual Conference